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Background. Vitamin D has been reported to regulate innate immunity by controlling the expression of antimicrobial peptides
(AMPs). Objective. We investigated the eﬀect of calcipotriol on the expression of AMPs in human cultured keratinocytes. Methods.
Keratinocytes were treated with lipopolysaccharide (LPS), TNF-α, Calcipotriol and irradiated with UVB, cultured, and harvested.
Toassesstheexpression ofhuman betadefensin-2andLL-37in thecontrolgroup,notexposed toanystimulants,theexperimental
group was treated with LPS, TNF-α, or UVB, and another group was treated again with calcipotriol; reverse transcriptase-
polymerase chain reaction, Western blotting, and immunohistochemical staining were performed. Results. In the experimental
group treated with LPS, UVB irradiation, and TNF-α, the expression of β-defensin and LL-37 was increased more than in the
control group and then decreased in the experimental group treated with calcipotriol. Conclusions.C a l c i p o t r i o ls u p p r e s s e dH B D -
2 and LL-37, which were stimulated by UVB, LPS, and TNF-α.
Copyright © 2009 Beom Joon Kim et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Antimicrobial peptides (AMPs) are small molecular weight
proteins with a broad spectrum of antimicrobial activity
against bacteria, viruses, and fungi [1, 2]. They are involved
in the ﬁrst line of defense as well as coordination of the
innate and adaptive immune system [3]. In addition, recent
studies have shown that AMPs can function as chemokines,
proteinases, and neuropeptides [4]. Many AMPs have been
found in a variety of tissues such as respiratory, urogenital,
and skin epithelium [5–7]. Human ß-defensin (HBD) and
cathelicidin have been identiﬁed as the principal peptides in
the skin.
These AMPs exhibit an imbalance or dysregulation in
some inﬂammatory skin diseases such as atopic dermatitis
and psoriasis. LL-37 as a peptide form of human cathelicidin
and HBD-2 both have been reported to be downregulated
in the skin of patients with atopic dermatitis compared to
patients with psoriasis [6]. Unlike atopic dermatitis, HBD
and cathelicidin are strongly increased in keratinocytes in
psoriatic plaques [8]. Considering these ﬁndings, AMPs
have been thought to play a role in the pathogenesis of
inﬂammatory skin diseases.
The mechanisms underlying the regulation of AMP
expression remain poorly understood. Many cytokines, Toll-
like receptors (TLRs), and vitamin D are thought to be
involved in the regulation of AMP expression. The activation
of Toll-like receptors has been reported to lead to the nuclear
factor kappa B (NFκB) dependent induction of a variety of
AMPs including the defensins [9–11]. HBD-2 and -3 have
beenreportedtobeinducedbyinterleukin(IL)-1α,IL-β,and
the tumor necrosis factor (TNF)-α [10, 12].
Recently, vitamin D has been reported to be important
in cutaneous immune modulation as well as calcium regu-
lation and bone metabolism. Vitamin D induces epidermal
keratinocytes to growth arrest, diﬀerentiation, and changes2 Clinical and Developmental Immunology
in cytokine expression [13]. In addition, vitamin D has been
associated with an increase in the expression of LL-37 in
cultured human keratinocytes and in human skin in vivo
[14]. Moreover, the vitamin D response element has been
identiﬁed in the cathelicidin promoter [15]. Vitamin D-
induced cathelicidin worsens the inﬂammation associated
with psoriasis; however, vitamin D has been used for the
treatment of psoriasis. The molecular eﬀects of vitamin D on
theAMPshavenotbeenelucidatedinpatientswithpsoriasis.
In this study, we investigated the eﬀects of calcipotriol, a
vitamin D3 analogue on the expression of AMPs in human
cultured keratinocytes. The results showed that calcipotriol
suppressed the upregulated expression of hBD-2 and LL-37,
stimulated by ultraviolet B (UVB), lipopolysaccharide (LPS),
and TNF-α.
2.MaterialsandMethods
2.1. Cell Culture. The keratinocytes were cultured in Ker-
atinocyteBasalMedium(Cambrex,Walkersville,MD.,USA),
supplemented with KGM SingleQuots (Cambrex, Walk-
ersville, MD., USA) grown in a 75cm2 ﬂask and incubated
with 5% CO2 at 37
◦C. The cultured keratinocytes were
divided in the amount of 2 × 105/mL and plated in a
standard ﬂat bottomed 10cm2 polystyrene plate. The cells
were starved overnight in KBM supplemented with free
KGM. Some cells were then irradiated with 20mJ/cm2 of
UVB and treated with LPS (Sigma, St. Louis, MO., USA)
5μg/mL, TNF-α (Sigma, St. Louis, MO., USA) 100U/mL,
and Calcipotriol (Sigma, St. Louis, MO., USA) 10
−9μga n d
incubated for 6, 12, and 24 hours.
2.2. Ultraviolet B Irradiation (UVB). The dose of irradi-
ation used was 20mJ/cm2; this dose was chosen based
on preliminary data. UVB irradiation was delivered with
a Philips TL 20W/12 (Eindhoven, The Netherlands), a
ﬂuorescent bulb emitting 280–320nm wavelength with a
peak at 313nm. Before UVB irradiation, the medium was
removed and covered with phosphate buﬀered saline (PBS).
Irradiation output was monitored with a Waldmann UV-
meter (Waldmann, Villigen-Schwenningen, Germany).
2.3. Preparation of Primers. We synthesized the PCR primers
based on Gene Bank data. The primers were chemically syn-
thesized using a DNA synthesizer (Pharmacia, Bj¨ orkgatan,
Uppsala, Sweden). The sequences were as follows:
hBD-2 (128bp):
5 -ATCTCCTCTTCTCGTTCCTC-3  (sense),
5 -ACCTTCTAGGGCAAAAGACT-3 (anti-sense).
LL-37 (203bp):
5 -CTGATGCCTCTTCCAGGTGT-3  (sense),
5 -GAGGGAGCCCTTTCTGAATC-3  (anti-sense).
GAPDH (593bp):
5 -CCACCCATGGCAAATTCCATGGCA-3  (sense),
5 -GGTGCTGCTTGTTAGGAGGTCAAGTAAAGG-
GC-3  (anti-sense).
2.4. Reverse Transcription-Polymerase Chain Reaction (RT-
PCR). Total RNA was isolated from the cultured ker-
atinocytes using TRIzol reagent (Invitrogen, Carlsbad, CA,
USA). To the cells, 1mL of TRIzol reagent was added in a
culture dish. After 5 minutes at room temperature, 0.2mL of
chloroform was added per 1mL of TRIzol reagent; the tubes
were shaken vigorously by hand for 15 seconds and then they
were incubated at 15
◦Ct o3 0
◦C for 3 minutes. The mixtures
were centrifuged at 12,000rpm at 4◦C for 15 minutes, the
upper aqueous phase was transferred to a fresh tube, and the
same volume of 2-propanol was added. After the incubation
at 4◦C for 15 minutes, the specimen was centrifuged at
12,000rpm at 4◦C for 15 minutes. The supernatant was
removed, then washed with 500μl of 70% ethanol, and
centrifuged at 12,000 rpm at 4◦C for 5 minutes; the RNA
pellet was then brieﬂy dried. The puriﬁed RNA was dissolved
in diethyl pyrocarbonate- distilled water (DEPC-DW) 30μl.
Next, 3μg of total cellular RNA was reverse transcripted at
42
◦Cf o r3 0m i n u t e si n2 0μl volume containing 1μlr e v e r s e
transcriptase (TaKaRa, Shiga, Japan), 10X buﬀer 2μl, 10mM
dNTP2μl(dNTPmix),oligodTprimer1μl,RNaseinhibitor
0.5μl ,a n d2 5m MM g C l 24μl.
Then, 2μl of each cDNA sample from the RT-PCR was
ampliﬁed by PCR in 25μl containing 10X buﬀer 2.5μl,
25mM MgCl2 2.5μl, and 10pmol 0.75μlp r i m e r .
The thermal cycle proﬁles were as follows: 94
◦Cf o r5
minutes, 35 cycles at 94
◦Cf o r1m i n u t e ,5 9
◦Cf o r1m i n u t e ,
72
◦C for 1 minute, and a ﬁnal extension step at 72
◦Cf o r1 0
minutes.
2.5. Electrophoresis. The products were run on 1.5% agarose
gel containing 1μg of ethidium bromide per millimeter;
20μl of reaction mixture was mixed with loading buﬀer
separated by electrophoresis for 15 minutes at 100 voltage
and visualized by UV transillumination.
2.6. Quantitative Analysis. Densitometry was performed on
the hybrids of the PCR products of hBD-2, LL-37 and
GAPDH, and the DIG on chemiluminescent ﬁlm was
calculated (volume of hBD-2/volume of GAPDH X100,
volume of LL-37/volume of GAPDH X100).
2.7. Statistical Analysis. T h ea m o u n to fh B D - 2a n dL L - 3 7i n
the keratinocytes between the control and stimulated groups
was statistically compared using the ANOVA.
2.8. Western Blotting. The cultured keratinocytes were lysed
in a buﬀer containing 50mM Tris-Cl (pH 8.0), 150mM
NaCl, 0.02% sodium azide, 100μg/mL phenylmethanesul-
fonyl ﬂuoride (PMSF), 1μg/mL aprotinin, and 1% Triton
X100, and then centrifuged at 12,000rpm at 4◦Cf o r3 0
minutes. The supernatant was transferred to a new tube.
Then,30μgofsolubleproteinwasloadedontoa15%sodium
dodecyl sulfate polyacrylamide gel for electrophoresis (SDS-
PAGE) with a sample buﬀer containing 1M Tris and glycerol
50%; the samples were heated at 95
◦C for 5 minutes prior to
loading the gel.Clinical and Developmental Immunology 3
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Figure 1: The expression of hBD-2 mRNA in keratinocytes was upregulated when stimulated with LPS, TNF-α, and UVB irradiation at 6,
12, and 24 hours. The hBD-2 mRNA expression was decreased after treatment with calcipotriol (CA). ∗: Statistically signiﬁcant between UV
and CA + UV (P<. 01). #: Statistically signiﬁcant between LPS and CA + LPS (P<. 01). +: Statistically signiﬁcant between TNF-s and CA +
TNF-a (P<0.01).
For detection of LL-37 and hBD-2, the separated
proteins, from the gel electrophoresis, were transferred onto
a nitocellulose membrane (Osmonics, Milwaukee, WI, USA)
at 0.16A for 1 hour. The membrane was washed three times
with Tris-buﬀered saline tween 20 (TBST) and blocked with
5% skim milk for 1 hour at room temperature. Following
this, the membrane was incubated overnight at 4◦Cw i t h
goat antihuman hBD-2 polyclonal antibodies (1:1000 in
5% bovine serum albumin, SantaCruz, Delaware, CA, USA)
or goat antihuman LL-37 polyclonal antibodies (1:1000
in 5% bovine serum albumin, SantaCruz, Delaware, CA,
USA) and then washed three times with TBST. Then,
the secondary mouse anti-goat peroxidase conjugated
antibodies (1:2000 in blocking solution, SantaCruz,
Delaware, CA, USA) were incubated for 1 hour at room
temperature.
After washing the membrane with TBST, the membrane
was developed with electrochemiluminescence (ECL) solu-
tion (SantaCruz, Delaware, CA, USA) for 3 minutes then
exposed to X-ray ﬁlm (Roche, Indianapolis, IN, USA).4 Clinical and Developmental Immunology
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Figure 2: Expression of hBD protein in keratinocytes were
evaluated by Western blotting using polyclonal antibody to hBD at
6, 12, and 24 hours post stimulation. The expression of hBD was
decreased after additional treatment with calcipotriol compared
to stimulation with LPS, TNF-α, and UVB irradiation in the
keratinocytes.
2.9. Immunohistochemistry (IHC) for hBD-2. The ker-
atinocytes were cultured on a coverslip (Nunc, Rochester,
NY, USA). The cells were ﬁxed for 10 minutes in 4%
paraformaldehydeandwashedthreetimesfor5minuteswith
PBS. Endogenous peroxidase was inactivated by incubation
with 3% hydrogen peroxide at room temperature for 5
minutes and blocked with 3% BSA for 20 minutes followed
by washing. The cells were incubated overnight at 4◦Cw i t h
goatanti-hBD-2polyclonalantibodies,diluted1:100inPBS,
thenrinsedthreetimeswithPBS,andincubatedwithdonkey
antigoat peroxidase-conjugated antibodies (1:200 in PBS)
for 1 hour at room temperature. After washing three times,
the cells were immersed in 3,3 -diaminobenzidine (DAKO,
Glostrup, Denmark) and then rinsed with distilled water.
2.10. Immunohistochemistry (IHC) for LL-37. The ker-
atinocytes were cultured on a coverslip (Nunc, Rochester,
NY, USA). The cells were ﬁxed for 10 minutes in 4%
paraformaldehydeandwashedthreetimesfor5minuteswith
PBS. Endogenous peroxidase was inactivated by incubation
with 3% hydrogen peroxide at room temperature for 5
minutes and blocked with 3% BSA for 20 minutes, followed
by washing. The cells were incubated overnight at 4◦Cw i t h
goat anti-LL-37 polyclonal antibodies, diluted 1:100 in PBS,
rinsed three times with PBS, and incubated with donkey
antigoat peroxidase-conjugated antibodies (1:200 in PBS)
for 1 hour at room temperature. After washing three times,
the cells were immersed in 3,3 -diaminobenzidine (DAKO,
Glostrup, Denmark) and rinsed with distilled water.
3. Results
3.1. Results for hBD
3.1.1. RT-PCR. hBD-2 mRNA expression was not detected
in the cultured keratinocytes of the unstimulated con-
trols. The HBD-2 mRNA expression was upregulated in
the UVB-irradiated, LPS, and TNF-α-stimulated groups.
The stimulant-induced upregulation of HBD-2 mRNA
expression was decreased after treatment with calcipotriol
(Figure 1). These results were statistically signiﬁcant when
compared to the results of the control group (P<. 001).
3.1.2. Western Blotting. hBD-2 protein expression was
assessed by Western blotting using polyclonal antibodies
against hBD-2 at 6, 12, and 24 hours after stimulation. The
levels of hBD-2 protein expression in the UVB-irradiated,
LPS, and TNF-α-treated group were more intense than in
the unstimulated control group. The expression of hBD
decreased after additional treatment with calcipotriol com-
pared to the stimulated group, with LPS, TNF-α, and UVB
irradiation in the keratinocytes (Figure 2).
3.1.3. Immunohistochemistry (IHC). hBD-2 protein expres-
sioninthekeratinocyteswasquantiﬁedviaIHCanalysis.The
UVB-irradiated, LPS, and TNF-α-stimulated groups stained
more strongly for hBD-2 protein expression than did the
unstimulated groups. In the additional groups treated with
calcipotriol, there was a less intense response than with
exposure to the stimulants (Figure 3).
3.2. Results of LL-37
3.2.1. RT-PCR. The expression of LL-37 mRNA in ker-
atinocytes was also upregulated when stimulated with LPS,
TNF-α, and UVB irradiation at 6, 12, and 24 hours. Similar
to the results of hBD-2, LL-37 mRNA expression was
decreased after treatment with calcipotriol (Figure 4). These
results were statistically signiﬁcant when compared to the
results of the control group (P<. 001).
3.2.2. Western Blotting. LL-37 protein expression was
assessed via Western blotting using polyclonal antibodies
against hBD-2 at 6, 12, and 24 hours after stimulation. The
levelofLL-37proteinexpressionintheUVB-irradiated, LPS,
and TNF-α-treated groups was more intense than observed
in the unstimulated control group. The expression of LL-
37 decreased after additional treatment with calcipotriol
compared to the keratinocytes stimulated with LPS, TNF-α,
and UVB irradiation (Figure 5).
3.2.3. Immunohistochemistry (IHC). LL-37 protein expres-
sion in the cultured keratinocytes was quantiﬁed by IHC
analysis. The UVB-irradiated, LPS and TNF-α-stimulated
groups stained more strongly for LL-37 protein expression
than did the unstimulated groups. In the additional groups
treated with calcipotriol the results were less intense than
when exposed to the stimulants (Figure 6).
4. Discussion
AMPs were ﬁrst found to act as endogenous antibiotics
involved in destroying microbes. Currently, they are thought
to play an important role in triggering and coordinating
innate and adaptive immunity. Among the more than 20
AMPs, the cathelicidins and defensins are the best charac-
terized in the skin. Defensins, as cationic peptides, contain
6 to 8 cysteine residues that form characteristic disulﬁdeClinical and Developmental Immunology 5
Control UV LPS TNF-α CA CA + UV CA + LPS CA + TNF-α
Defensin-2
IHC
Figure 3: Immunostaining for hBD was more intense on LPS, TNF-α treated, and UV irradiated groups than in the normal control. In the
additional groups treated with calcipotriol for hBD, the results were less intense than the stimulant groups.
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Figure 4: The expression of LL-37 mRNA in the keratinocytes was also upregulated when stimulated with LPS, TNF-α, and UVB irradiation
at 6, 12, and 24 hours. Similar to the hBD-2 results, LL-37 mRNA expression decreased after treatment with calcipotriol. ∗: Statistically
signiﬁcant between UV and CA + UV (P<. 01). #: Statistically signiﬁcant between LPS and CA + LPS (P<. 01). +: Statistically signiﬁcant
between TNF-s and CA + TNF-a (P<. 01).6 Clinical and Developmental Immunology
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Figure 5: The expression of LL-37 protein in keratinocytes was
evaluated by Western blotting using polyclonal antibody to LL-37
at 6, 12, and 24 hours post stimulation. The expression of LL-
37 was downregulated after additional treatment with calcipotriol
compared to the stimulated keratinocytes with LPS, TNF-α,a n d
UVB irradiation.
bridges [16]. Among alpha, beta, and theta defensins,
HBDs 1 to 4 are expressed in keratinocytes. HBDs 2 to 4
can be induced by calcium and phorbol 12 myristate 13
acetate (PMA) and can be inhibited by retinoic acid [17].
Cathelicidins are an important AMP family in the skin,
and the precursor protein, human cationic antimicrobial
peptide 18kDa (hCAP 18), is processed to LL-37 [18]. In
humankeratinocytes,cathelicidinsareinducedbyinfections,
interleukin-6, and wounds [19, 20].
The expression and function of the AMPs are important
for the appropriate modulation of immunity. In the case
of atopic dermatitis, the expressions of both HBD-2 and
LL-37 are signiﬁcantly decreased in skin lesions [6]. These
distinct defects of immune defense account for the increased
incidence of skin infections with this disorder. The reduction
of AMP expression is thought to be caused by the inhibitory
eﬀects of IL-4 and IL-13 on TNF-α and interferon (IFN)-γ
stimulation in keratinocytes [21].
The mechanisms of AMP regulation in keratinocytes are
incompletely understood. The expression of the AMPs is
aﬀected by various factors such as UVB, infections, inﬂam-
matory cytokines, and vitamin D. Cathelicidin is induced
by vitamin D when TLR-2 and the cytokine transforming
growth factor-β are activated after a skin injury [20]. Low-
dose UVB has been reported to upregulate the AMPs and
a permeability barrier functions via vitamin D [22]. TNF-α
induces the expression of HBD-2 and 3 [9, 12]. The results
of this study conﬁrmed prior ﬁndings that UVB, LPS, and
TNF-α increased the expression of HBD-2 and LL-37.
Vitamin D is an important regulator of cutaneous
immunity in addition to its role in calcium homeostasis and
bone metabolism. It has been reported to regulate innate
immunity and enable eﬃcient antimicrobial defenses. Sev-
eralresearchgroupsconﬁrmedthatcathelicidinexpressionis
regulated through the vitamin D3 pathway and cathelicidin
is a direct target of vitamin D3 in keratinocytes [14, 15].
In keratinocytes, human cathelicidin is directly regulated
by 1,25-dihydroxyvitamin D3 (1,25D3) through a vitamin
D3 responsive element (VDRE) in the human cathelicidin
gene CAMP [23]. Additional elements of the vitamin D3
signalling cascade have been identiﬁed that lead to increased
cathelicidin such as recruitment of coactivators or epigenetic
changes such as histone acetylation [24]. This inducing
eﬀect of vitamin D analogs on cathelicidin expression was
conﬁrmed in cell culture experiments using primary ker-
atinocytes: Vitamin D analogs such as calcipotriol induced
cathelicidin through activation of the VDR and subsequent
CAMP transcription.
SeveralstudieshaveshownthatAMPsarealsoinvolvedin
inﬂammatory skin diseases such as rosacea and psoriasis [25,
26]. Recent publications highlight the role of dysregulated
expression of AMPs in the pathogenesis of psoriasis. HBD-
2 and cathelicidin are strongly increased in keratinocytes
in psoriatic plaques6. In a recent study, cathelicidin LL-37
isolated from lesional skin was shown to form complexes
with human self-DNA to activate plasmocytoid dendritic
cells (pDCs) [8]. These pDCs released IFN-α to activate
the T cell response leading to cutaneous inﬂammation.
In addition, cathelicidin has been shown to induce the
expression of proinﬂammatory cytokines in keratinocytes,
angiogenesis, chemotaxis of immune cells, and wound repair
[27–29].
Strategies to decrease cathelicidin in keratinocyte by
targeting vitamin D3 metabolism and signaling might be
beneﬁcial in psoriasis. However, paradoxically for a long
time vitamin D3 analogs have been used in the therapy
of psoriasis. As vitamin D3 analogs activate the vitamin
D receptor, we would expect that they induce cathelicidin
presumably aggravating inﬂammation in psoriasis. Still, the
opposite is true: vitamin D analogs are a mainstay in the
topical treatment of psoriasis. They ameliorate cutaneous
inﬂammation and reverse morphological changes within
lesionalskin[30].Todatemechanismsthatcouldexplainthis
paradoxical eﬀect of vitamin D analogue for psoriasis have
not been completely examined yet.
This study demonstrated that previously increased AMPs
likepsoriaticskinlesionscouldbesuppressedbycalcipotriol.
As seen in this study with RT-PCR, Western blotting, and
immunohistochemical staining, upregulated HBD-2 and LL-
37 were suppressed after treatment with calcipotriol, a
vitamin D analogue. Although its inhibitory action was
not time-dependent, calcipotriol decreased the expression of
the AMPs stimulated by UVB, LPS, and TNF-α. Therefore,
vitamin D appears to downregulate increased HBD-2 and
LL-37 in stimulated keratinocytes. Thus, we speculate that
vitaminDmightinduceAMPsundernoninﬂammatorycon-
ditions, on the contrary downregulate previously induced
AMPs under inﬂammatory conditions like psoriatic skin.
Recent published study analyzed the expression of HBD and
cathelicidin in psoriatic plaques before and after treatment
with the vitamin D analogue calcipotriol [31]. Keratinocytes
in lesional psoriatic plaques showed decreased expression
of the AMPs HBD2 and HBD3 after topical treatment with
calcipotriol. In contrast, cathelicidin antimicrobial peptide
expression was increased by calcipotriol. Also, vitamin
D analogs induced cathelicidin through activation of the
vitamin D receptor and MEK/ERK signaling and blocked IL-
17A induced HBD2 expression in cultured human epidermal
keratinocyte. These studies suggest that vitamin D analogs
diﬀerentially alter AMP expression in lesional psoriaticClinical and Developmental Immunology 7
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Figure 6: Immunostaining of LL-37 was more intense in the LPS, TNF-α treated, and UV irradiated groups than in the normal control. In
the additional groups treated with calcipotriol, immunostaining for LL-37 was less intense than for the stimulant groups.
skin and cultured keratinocytes. Although our esperimental
results are contrary to current understanding of vitamin D
eﬀect on AMP, these results also might present possibility for
another pathway of vitamin D analogs in psoriasis patients.
Vitamin D signaling pathway is very complex and consists
of various elements. Further study that could make clear the
mechanism for explaining downregulating eﬀect of vitamin
D on the induced AMP expression is processing now. Future
experimental work on the molecular pathways and clinical
correlations are needed to understand AMP and vitamin D.
In conclusion, calcipotriol suppressed induced HBD-2
and LL-37, stimulated by UVB, LPS, and TNF-α. These
ﬁndings suggest that vitamin D modulates the expressions of
AMPs in chronic skin diseases with highly expressed AMPs.
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